Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: Evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor

Blood

Volumn 89, Issue 6, 1997, Pages 1944-1953

  Renesto, Patricia ^b   Si Tahar, Mustapha ^b   Moniatte, Marc ^b   Balloy, Viviane ^b   Van Dorsselaer, Alain ^b   Pidard, Dominique ^b   Chignard, Michel ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CATHEPSIN G; EPITOPE; LEUKOCYTE ELASTASE; MYELOBLASTIN; PROSTACYCLIN; SYNTHETIC PEPTIDE; THROMBIN; THROMBIN RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CALCIUM MOBILIZATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION;

EID: 0030968521     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.6.1944     Document Type: Article

References (47)

1. Nelken NA, Soifer SJ, Vu TKH, Charo IF, Coughlin SR: Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest 90:1614, 1992
2. Garcia JGN, Pavalko FM, Patterson CE: Vascular endothelial cell activation and permeability responses to thrombin. Blood Coagul Fibrinolysis 6:609, 1995
3. Lorant DE, Patel KD, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA: Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: A juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 115:223, 1991
4. Wright DG, Gallin JI: Secretory responses of human neutrophils: Exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo. J Immunol 123:285, 1979
5. Borregaard N, Lollike K, Kjeldsen L, Sengelov H, Bastholm L, Nielsen MH, Bainton DF: Human neutrophil granules and secretory vesicles. Eur J Haematol 51:187,1993
6. Harlan JM, Killen PD, Harker LA, Striker GE, Wright DG: Neutrophil-mediated endothelial injury in vitro. Mechanisms of cell detachment. J Clin Invest 68:1394, 1981
7. Varani J, Ginsburg I, Schuger L, Gibbs DF, Bromberg J, Johnson KJ, Ryan US, Ward PA: Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases. Am J Pathol 135:435, 1989
8. Renesto P, Vicart P, Paulin D, Chignard M: Protective effect of platelet activating factor antagonists on cultured endothelial cell lysis induced by elastase or activated neutrophils. Br J Pharmacol 117:902, 1996
9. Weksler BB, Jaffe EA, Brower MS, Cole OF: Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells. Blood 74:1627, 1989
10. McNicol A, Gerrard JM: Post-receptor events associated with thrombin-induced platelet activation. Blood Coagul Fibrinolysis 4:975, 1993
11. Brass LF: Issues in the development of thrombin receptor antagonists. Thromb Haemost 74:499, 1995
12. Selak MA, Smith JB: Cathepsin G binding to human platelets. Evidence for a specific receptor. Biochem J 266:55, 1990
13. Si-Tahar M, Renesto P, Falet H, Rendu F, Chignard M: The phospholipase C/protein kinase C pathway is involved in cathepsin G-induced human platelet activation: Comparison with thrombin. Biochem J 313:401, 1996
14. Selak MA: Cathepsin G and thrombin: Evidence for two different platelet receptors. Biochem J 297:269, 1994
15. Vu TKH, Hung DT, Wheaton VI, Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 91:1405, 1991
16. 2+ mobilization. FEBS Lett 288:123, 1991
17. Coughlin SR: Protease-activated receptors start a family. Proc Natl Acad Sci USA 91:9200, 1994
18. Hollenberg MD: Protease-mediated signalling: New paradigms for cell regulation and drug development. Trends Pharmacol Sci 17:3, 1996
19. Bahou WF, Kutok JL, Wong A, Potter CL, Coller BS: Identification of a novel thrombin receptor sequence required for activation-dependent responses. Blood 84:4195, 1994
20. Bahou WF, Coller BS, Potter CL, Norton KJ, Kutok LJ, Goligorsky MS: The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation. J Clin Invest 91:1405, 1993
21. Gersztein RE, Chen J, Ishii M, Ishii K, Wang L, Nanevicz T, Turk CW, Vu TKH, Coughlin SR: Specificity of the thrombin receptor for agonist peptide is identified by its extracellular surface. Nature 368:648, 1994
22. Molino M, Blanchard N, Belmonte E, Tarver AP, Abrams C, Hoxie JA, Cerletti C, Brass LF: Proteolysis of the human and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J Biol Chem 270; 11168, 1995
23. Renesto P, Chignard M: Enhancement of cathepsin G induced platelet activation by leukocyte elastase: Consequence for neutrophil-mediated platelet activation. Blood 82:139, 1993
24. Schwartz B, Vicart P, Delouis C, Paulin D: Mammalian cell lines can be efficiently established in vitro upon expression of the SV40 large T antigen driven by a promoter sequence derived from the human vimentin gene. Biol Cell 73:7, 1991
25. Vicart P, Testut P, Schwartz B, Llorens-Cortes C, Perdomo JJ, Paulin D: Cell adhesion markers are expressed by a stable human endothelial cell line transformed by the SV40 large T antigen under vimentin promoter control. J Cell Physiol 157:41, 1993
26. Braun NJ, Bodmer JL, Virca GD, Metz-Virca G, Maschler R, Bieth JG, Schnebli HP: Kinetic studies on the interaction of eglin C with human leukocyte elastase and cathepsin G. Biol Chem Hoppe Seyler 368:299, 1987
27. Renesto P, Halbwachs-Mecarelli L, Nusbaum P, Lesavre P, Chignard M: Proteinase 3: A neutrophil proteinase with activity on platelets. J Immunol 152:4612, 1994
28. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440, 1985
29. Vorm O, Roepstorff P: Peptide sequence information derived by partial acid hydrolysis and matrix-assisted laser desorption/ionization mass spectrometry. Biol Mass Spectrom 23:734, 1994
30. Hirata M, Hayashi Y, Ushikubi F, Yokota Y, Kageyama R, Nakanishi S, Narumiya S: Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature 349:617, 1991
31. Brower MS, Waltz DA, Carry KE, Fenton II JW: Human neutrophil elastase alters human α-thrombin function: Limited proteolysis near the γ-cleavage site results in decreased fibrinogen clotting and platelet-stimulatory activity. Blood 69:813, 1989
32. Brezniak DV, Brower MS, Witting JI, Waltz DA, Fenton II JW: Human α-to ζ-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retained. Biochemistry 29:3536, 1990
33. Hartmann T, Ruoss SJ,Caughey GH: Modulation of thrombin and thrombin receptor peptide mitogenicity by human lung mast cell tryptase. Am J Physiol 11:L113, 1994
34. Blackhart BD, Emilsson K, Nguyen D, Teng W, Martelli AJ, Nystedt S, Sundelin J, Scarborough RM: Ligand cross-reactivity within the proteinase-activated receptor family. J Biol Chem 271:16466, 1996
35. Mirza H, Yatsula V, Bahou WF: The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. Molecular characterization and evidence for functional coupling to the thrombin receptor. J Clin Invest 97:1705, 1996
36. Hung DT, Vu TKH, Wheaton VI, Ishii K, Coughlin SR: Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J Clin Invest 89:1350, 1992
37. Connolly AJ, Ishihara H, Kahn ML, Farese RV Jr, Coughlin SR: Role of the thrombin receptor in development and evidence for a second receptor. Nature 381:516, 1996
38. 2+ responses of protease-treated human platelets activated with α-thrombin and the tethered ligand peptide. Biochemistry 35:915,1996
39. Norton KJ, Scarborough RM, Kutok JL, Escobedo MA, Nannizzi L, Coller BS: Immunologic analysis of the cloned platelet thrombin receptor activation mechanism: Evidence supporting receptor cleavage, release of the N-terminal peptide, and insertion of the tethered ligand into a protected environment. Blood 82:2125, 1993
40. Bieth J: Elastases: Catalytic and biological properties, in Mecham R (ed): Regulation of Matrix Accumulation. New York, NY, Academic, 1986, p 217
41. Nakajima K, Powers JC, Ashe BA, Zimmerman M: Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. J Biol Chem 254:4027, 1979
42. Kam CM, Kerrigan JE, Dolman KM, Goldschmeding R, Von dem Borne AE, Powers JC: Substrate and inhibitor studies on proteinase 3. FEBS Lett 297:119, 1992
43. Yamashita M, Fukui H, Sugama K, Horio Y, Ito S, Mizuguchi H, Wada H: Expression cloning of a cDNA encoding the bovine histamine H1 receptor. Proc Natl Acad Sci USA 88:11515, 1991
44. Van Obberghen-Schilling E, Pouyssegur J: α-thrombin receptors and growth signaling. Semin Thromb Hemost 19:378, 1993
45. Evangelista V, Rajtar G, de Gaetano G, White JG, Cerletti C: Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: The activity of cathepsin G is not prevented by antiproteinase. Blood 11:2379, 1991
46. Owen CA, Campbell MA, Sannes PL, Boukedes SS, Campbell EJ: Cell surface-bound elastase and cathepsin G on human neutrophils: A novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinase. J Cell Biol 131:775, 1995
47. Owen CA, Campbell MA, Boukedes SS, Campbell EJ: Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G. J Immunol 155:5803, 1995